MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1)-Reference-Cited by-同舟云学术

MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1)

Published:2022-06-01 Issue:6 Volume:13 Page:14159-14174
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Bi Wen¹^ORCID,Yang Mengyue²,Xing Pengfei¹,Huang Tao¹^ORCID

Affiliation:

1. Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China

2. Department of Cardiovascular, The First Hospital of China Medical University, Shenyang, China

Funder

Shenyang Science and Technology Bureau

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2083855

Reference50 articles.

1. Osteosarcoma incidence and survival rates from 1973 to 2004

2. Cancer statistics, 2022

3. Future Directions in the Treatment of Osteosarcoma

4. Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas

5. MicroRNA: A signature for cancer progression

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mg alloys with antitumor and anticorrosion properties for orthopedic oncology: A review from mechanisms to application strategies;APL Bioengineering;2024-04-17

2. Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review;Current Molecular Pharmacology;2024-01-16

3. Advances in miR-331 Research in Human Cancer;Advances in Clinical Medicine;2024

4. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy;Journal of Orthopaedic Surgery and Research;2023-11-22

5. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer;Aging;2023-07-25